Abbott Laboratories (NYSE:ABT) will release earnings for the fourth quarter before the opening bell on Thursday, Jan. 22.
Analysts expect the Abbott Park, Illinois-based company to report fourth-quarter earnings of $1.49 per share. That’s up from $1.34 per share in the year-ago period. The consensus estimate for Abbott’s quarterly revenue is $11.8 billion (it reported $10.97 billion last year), according to Benzinga Pro.
On Jan. 20, Abbott received CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms.
Shares of Abbott fell 0.3% to close at $120.73 on Wednesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort …